Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Judith D. Bebchuk"'
Autor:
John S. Kennedy, Judith D. Bebchuk, Shawn A. Menefee, Jasmine Tan-Kim, Cristina H. O’Day, Caryl S. Reinsch, Emily L. Whitcomb
Publikováno v:
Journal of Minimally Invasive Gynecology. 22:1278-1286
Study Objectives To evaluate the incidence, detection, characteristics, and management of urinary tract injury in a cohort undergoing laparoscopic hysterectomy, and to identify potential risk factors for urinary tract injury with laparoscopic hystere
Publikováno v:
International Journal of Dermatology. 54:e442-e445
Publikováno v:
Journal of Dermatological Treatment. 26:230-234
Psoriasis may or may not be associated with a higher risk for myocardial infarction (MI). We sought to assess differences in MI incidence between control, mild psoriasis and severe psoriasis patients.We performed a retrospective cohort study of Kaise
Autor:
Glenn J. Jaffe, Timothy L Jackson, Jason S. Slakter, Kelly R. Smith, Robert Petrarca, Pravin U. Dugel, Jeffrey Nau, Judith D. Bebchuk
Publikováno v:
Ophthalmology. 120:1597-1603
Purpose To report the fluorescein angiography (FA) and optical coherence tomography (OCT) results of a clinical trial of epimacular brachytherapy (EMBT) used for the treatment of neovascular age-related macular degeneration (AMD). Design Pivotal mult
Autor:
Jeffrey Nau, Adiel Barak, Michael A Singer, Judith D. Bebchuk, Elias Reichel, Susanne Binder, Timothy L Jackson, Pravin U. Dugel
Publikováno v:
Ophthalmology. 120:317-327
Purpose To evaluate the safety and efficacy of epimacular brachytherapy (EMBT) for the treatment of neovascular age-related macular degeneration (AMD). Design Multicenter, randomized, active-controlled, phase III clinical trial. Participants Four hun
Publikováno v:
Journal of drugs in dermatology : JDD. 14(2)
The use of tumor necrosis factor inhibitors (TNFi) has been associated with a reduced incidence of type 2 diabetes mellitus.To compare changes in hemoglobin A1C and fasting glucose for patients exposed to TNFi.In this retrospective cohort study, pati
Publikováno v:
Journal of the American Academy of Dermatology. 72(5)
Autor:
Judith D. Bebchuk, Rebecca A. Betensky
Publikováno v:
Statistics in Medicine. 24:359-378
In many settings, one would expect that the hazard for a terminal event would change with the occurrence of an intermediate event. For example, in an AIDS clinical trial, it is of interest to assess whether there is a difference between treatments in
Autor:
Lawrence Fox, Eileen T. Denning, H. Clifford Lane, Donald I. Abrams, Norman P. Markowitz, Rita Verheggen, Douglas Zeh, Richard T. Davey, Judith D. Bebchuk, James H. Sampson
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 29:221-231
The effect of intermittent courses of recombinant interleukin-2 (rIL-2) on HIV-1 load in patients receiving combination antiretroviral therapy remains uncertain. CPCRA 059 was an open-label, randomized, multicenter trial in which 511 patients with HI
Autor:
Laura A McNay, Jorge A Tavel, Karen Oseekey, Cathy M McDermott, David Mollerup, Judith D Bebchuk, null for the ESPRIT Group
Publikováno v:
Controlled Clinical Trials. 23:59-66
While accepted as serving an important function to safeguard human subjects, the process of obtaining regulatory approvals to conduct clinical trials is generally regarded as cumbersome and time-consuming. For large multinational trials, U.S. federal